4//SEC Filing
Boyle Kevin S. Sr. 4
Accession 0000899243-22-013119
CIK 0001107421other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:30 PM ET
Size
11.2 KB
Accession
0000899243-22-013119
Insider Transaction Report
Form 4
Boyle Kevin S. Sr.
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-03-30+2,000,000→ 2,000,000 totalExercise: $0.66Exp: 2032-03-29→ Common Stock (2,000,000 underlying)
Footnotes (1)
- [F1]One-sixteenth of the shares underlying the option vest in equal quarterly installments commencing three months after January 1, 2022, subject to the Reporting Person's continued service through each such date.
Issuer
Alaunos Therapeutics, Inc.
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001880600
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 4:30 PM ET
- Size
- 11.2 KB